
JANX
Healthcare · Biotechnology · $695.7M market cap
$11.37-0.13 (-1.1%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +11.4% over 90 days · 30-day revisions 5 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | After the close | -0.45 | -0.34 | +24.4% |
| Aug 6, 2026 | After the close | -0.26 | -0.35 | -34.6% |
| May 7, 2026 | After the close | -0.52 | -0.39 | +25.0% |
| Feb 26, 2026 | Time not confirmed | -0.65 | -0.51 | +21.5% |
| Nov 6, 2025 | After the close | -0.61 | -0.39 | +36.1% |
| Aug 7, 2025 | After the close | -0.48 | -0.55 | -14.6% |
| May 8, 2025 | After the close | -0.39 | -0.38 | +2.6% |
| Feb 27, 2025 | Time not confirmed | -0.43 | -0.36 | +15.6% |
| Nov 6, 2024 | After the close | -0.36 | -0.51 | -41.7% |
| Aug 7, 2024 | After the close | -0.29 | -0.11 | +62.1% |
| May 7, 2024 | After the close | -0.33 | -0.30 | +9.1% |
| Mar 8, 2024 | After the close | -0.39 | -0.25 | +35.9% |
| Nov 7, 2023 | After the close | -0.43 | -0.25 |
Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms technology to treat patients with cancer. The company's clinical candidates include JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical…
| +41.9% |
| Aug 8, 2023 | After the close | -0.51 | -0.42 | +17.6% |
| May 9, 2023 | After the close | -0.46 | -0.42 | +8.7% |
| Mar 10, 2023 | After the close | -0.49 | -0.39 | +20.4% |
| Nov 10, 2022 | After the close | -0.53 | -0.40 | +24.5% |
| Aug 9, 2022 | After the close | -0.39 | -0.41 | -5.1% |
| May 10, 2022 | After the close | -0.37 | -0.32 | +13.5% |
| Mar 18, 2022 | After the close | -0.31 | -0.33 | -6.5% |
| Nov 9, 2021 | After the close | -0.17 | -0.26 | -52.9% |
| Aug 10, 2021 | After the close | -0.16 | -0.15 | +6.3% |
| Jun 11, 2021 | After the close | 0.00 | -2.02 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | -2.63 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -2.20 | — |